Zhang Xiaobin
Associate Director, Takeda Pharmaceutical
Xiaobin Zhang is an Associate Director at Takeda specializing in bioanalytical science and immunogenicity for biologics and advanced therapeutics. With over a decade of experience spanning GMP/GLP environments, academia, and drug development, he has deep expertise in cell-based assay development, antibody characterization, and validation of bioanalytical methods supporting gene and protein-based medicines.
Seminars
Wednesday 18th November 2026
Industry Leader’s Fireside Chat: The Next Decade of LNP Characterization, Which Analytical Technologies Will Shape the Future of RNA Medicines?
9:00 am
- Which analytical technologies are generating the most excitement?
- What are the biggest characterization gaps today?
- Are we measuring the right CQAs?
- How will AI and automation transform analytical development?
- Which technologies will become standard over the next 5-10 years?
